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The 2.7 A˚ crystal structure of the 55-kDa N-terminal breakage-reunion domain of topoisomerase (topo) IV subunit A (ParC)
from Streptococcus pneumoniae, the first for the quinolone targets from a gram-positive bacterium, has been solved and
reveals a ‘closed’ dimer similar in fold to Escherichia coli DNA gyrase subunit A (GyrA), but distinct from the ‘open’ gate
structure of Escherichia coli ParC. Unlike GyrA whose DNA binding groove is largely positively charged, the DNA binding site of
ParC exhibits a distinct pattern of alternating positively and negatively charged regions coincident with the predicted
positions of the grooves and phosphate backbone of DNA. Based on the ParC structure, a new induced-fit model for sequence-
specific recognition of the gate (G) segment by ParC has been proposed. These features may account for the unique DNA
recognition and quinolone targeting properties of pneumococcal type II topoisomerases compared to their gram-negative
counterparts.
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INTRODUCTION
DNA topoisomerases are enzymes of vital cellular importance due
to their ability to alter DNA topology. Replication of duplex DNA
or recombination between DNA duplexes may cause the forma-
tion of DNA supercoils, knots and catenanes. The major role of
topoisomerases is to control DNA topology by transient breakage
of DNA strands. This activity is achieved through the formation of
covalent enzyme-DNA complexes linked via phosphotyrosine
bonds. Type I topoisomerases act on one strand of DNA whereas
type II enzymes pass a DNA duplex through a double-strand DNA
break, resulting in changes of DNA linking number in units of 1
and 2, respectively [1–3].
Type II topoisomerases comprise a family of structurally and
evolutionarily conserved enzymes common to all organisms [4]
and have been implicated in a variety of intracellular processes
including DNA replication, transcription and chromosome
segregation [5]. Because of their importance to the cell life cycle,
these enzymes have been a subject of intense drug development
studies and were identified as targets for a large number of natural
toxins, antimicrobial agents and anti-tumour therapeutics [6–8].
Based on sequence and structural criteria, type II topoisome-
rases are divided into two subclasses. The most common subclass,
type IIA, includes the bacterial enzymes topo IV and gyrase,
and eukaryotic topo II. Type IIB topos are structurally and
biochemically distinct, and comprise a single family member, topo
VI [2,9–11]. All members of the type IIA subclass exhibit
significant sequence and mechanistic similarity.
Bacterial genomes usually encode two type IIA enzymes, topo
IV and DNA gyrase, each composed of two subunits (ParC and
ParE in topo IV, GyrA and GyrB in gyrase) assembled into
a functional heterotetramer i.e. C2E2 and A2B2, respectively [6].
Both enzymes act by passing a duplex DNA segment through
a transient double-stranded DNA break in another helical region.
In the currently accepted model [9], the open enzyme clamp binds
a DNA segment termed the ‘gate’ or G-segment. The N-terminal
ATPase domains of the ParE (GyrB) subunits dimerize upon ATP
binding capturing the DNA duplex to be transported (T-segment).
The T-segment is then passed through a transient break in the G-
segment (opened by the N-terminal ParC (GyrA) domains), the
DNA is resealed and the T-segment released through a protein
gate prior to resetting of the enzyme to the open clamp form.
Although topo IV and gyrase share a high degree of similarity,
their cellular functions are different. Gyrase controls DNA super-
coiling and relieves topological stress arising from the translocation
of transcription and replication complexes along DNA. Gyrase is
unique in its ability to introduce negative supercoiling into the
DNA. By contrast, topo IV is a decatenating enzyme that resolves
interlinked daughter chromosomes following DNA replication.
The functional differences between gyrase and topo IV are attri-
buted to the non-specific binding of the C-terminal domain of the
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GyrA subunit that wraps DNA presenting a neighbouring T-
segment for passage through the G-gate. Removal of this domain
converts gyrase into an enzyme with topo IV-like activities, i.e.
ATP-dependent DNA relaxation and decatenation [12].
In addition to their unusual mechanisms, topo IV and gyrase
are also targets of clinically important quinolone drugs. Quino-
lones exert their bactericidal effects by interfering with DNA
breakage-reunion by topo IV and gyrase leading to double-
stranded DNA breaks at specific sites. Recent studies have
uncovered fundamental differences in quinolone action in gram-
positive vis-a`-vis gram-negative bacteria. For example, though
gyrase is the universal target of quinolones in gram-negative bac-
teria, topo IV is the primary (or dual) target of many quinolones in
gram-positive pathogens such as Streptococcus pneumoniae, a major
cause of pneumonia and other serious infections [13,14]. Second,
pneumococcal topo IV is more sensitive than gyrase to quinolone
inhibition in vitro, the inverse of that seen in E. coli [15]. Third,
quinolones trap S. pneumoniae topo IV (and gyrase) at DNA sites (G-
segments) that are distinct in sequence from those observed for E.
coli topo IV and gyrase [15]. These unique features emphasize the
need to analyze the structure of S. pneumoniae topo IV and how it
binds quinolones and DNA. Progress in these areas will be
important in understanding ParC-mediated resistance to quino-
lones and in developing dual targeting drugs that minimize the
emergence of resistance [13,16,17].
RESULTS AND DISCUSSION
Digestion with trypsin revealed that pneumococcal ParC is
organized into a 53-kDa N-terminal domain (ParC53, residues
23-487) and a compact 17-kDa C-terminal region (Figure 1A).
ParC53 was enzymatically inactive whereas a recombinant
ParC55 fragment (residues 1-490), when complemented with topo
IV ParE, reconstituted quinolone-promoted DNA cleavage (data
not shown). The DNA cleavage specificity of the ParC55-ParE
complex was identical to that of pneumococcal topo IV and
exhibited the same unique base recognition preferences of 24G/
+8C, 22A/+6T and+1G/+4C (relative to the DNA scission site
between nucleotide 21 and+1). These determinants are very
different from those of E. coli topo IV (preferences 21(A/G)
and+1(T/A)) and E. coli gyrase (a degenerate 20-bp consensus)
[15]. Sequence alignment with the N-terminal domains of E. coli
GyrA and ParC whose crystal structures have been solved [18,19]
shows greater similarity of S. pneumoniae ParC55 with E. coli GyrA
and S. pneumoniae GyrA (forms a GyrA58 (residues 17–529) tryptic
fragment via GyrA60, Figure 1B) than with E. coli ParC
(Figure 1C). However, these comparisons do not explain the
distinctive enzyme preferences in G-segment recognition. To gain
insight into the mechanism of S. pneumoniae topo IV and its
interaction with DNA and quinolones, the structure of the ParC55
fragment has been solved (Figure 2A) and the model was refined to
R = 22.30% (R-free = 27.55%) at 2.7 A˚ resolution using wild-type
ParC55 data (twinning fraction = 0.323, twinning operator = (k,-
h,l)). The crystallization of ParC55, the quinolone target from
gram-positive bacteria, and X-ray analysis were first reported by
our group in Acta Cryst. (2005) A61, C176.
Crystal structure of ParC55: a closed dimer with
a distinctively charged DNA binding groove
ParC55 forms a biological dimer in a ‘closed’ conformation in this
crystal form generating a ring-like structure with outer dimensions
of 1006100650 A˚ and with a central hole approximately 30 A˚ in
diameter, which is wide enough to pass a duplex DNA (Figure 2A).
This is in contrast to the ParC structure from E. coli which adopts
an ‘open’ dimer conformation [18] (Figure 2B), but similar to the
closed dimer of GyrA59 from E. coli [19] (Figure 2C). Each
monomer of ParC55 contains two distinct regions labeled ‘head’
and ‘tail’ and exhibits an overall structural fold similar to the one
observed for other topoisomerases [18–20]. The N-terminal
proximal head contains the CAP-like (catabolite gene activator
protein [21–23]) DNA-binding domain and the ‘tower’. The CAP-
like domain is composed of a helix-turn-helix structural motif
(helices a3 and a4) typical for DNA-binding proteins, with the
active site Arg 117 and Tyr 118 on the neighboring ‘100-122’ loop
(Figure 2A). The residues Ser 79 and Asp 83, which upon
mutation give rise to quinolone-resistant pneumococci, are located
primarily within the helix a4 in close proximity to the active-site
tyrosine and are oriented towards the predicted position of the
bound DNA. The ‘tower’ is positioned on the top of the CAP-like
domain and has largely a-helical and b-sheet structural organiza-
tion. High B-factor values and poor definition of several loops
indicate a high level of flexibility in this region. In the closed con-
formation, the ParC55 monomers form a tight contact between
the a3 helices with a mean center-to-center distance of 10 A˚
resulting in the protein-protein interface with a buried surface area
of 706 A˚2. This is less than in the case of E. coli GyrA where the
monomers form a protein-protein interface with a buried surface
area of 1,380 A˚2. The ‘recognition’ a4 helices are further apart
from each other by 5 A˚ in the case of the ParC55 dimer compared
to the E. coli GyrA dimer.
The ‘tail’ has a primarily a-helical core composition and forms
the so-called ‘primary’ dimer interface with a total buried surface
area of 2,001 A˚2. It is very similar to equivalent domains from E.
coli GyrA and E. coli ParC in terms of the overall core structure,
though its outer appearance is different from the ‘tail’ present in E.
coli GyrA due to a lack of extra surface loops (Figure 2A, C). Two
long helices (a14 and a18) emanate from the ‘tail’ domain and join
Figure 1. Comparison of type II topoisomerases from S. pneumoniae and E. coli. Schematic domain organization of (A) S. pneumoniae topoisomerase
IV, (B) S. pneumoniae gyrase (with the proteolytic fragments generated by trypsin digestion superimposed) and (C) graphical representation of the
sequence similarity scores for 500-residue N-terminal fragments of ParC (P72525) and GyrA (P72524) from S. pneumoniae and equivalent fragments of
ParC (P0AFI2) and GyrA (P0AES4) from E. coli calculated using ClustalW [49].
doi:10.1371/journal.pone.0000301.g001
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it to the ‘head’ domain (a14 directly and a18 through a flexible
loop and helix a19, respectively).
Superposition of the ‘closed’ S. pneumoniae ParC55 and ‘open’ E.
coli ParC dimers reveals several significant structural differences
potentially relevant to topo IV catalysis (Figure 2D). The process
of changing conformation from the ‘closed’ form to an ‘open’ one
will involve movement of the ‘heads’ away from each other,
increasing the average distance between them by approximately
30 A˚ and rotating them by 15 degrees relative to the tail protein
dimer interface and 20 degrees relative to the vertical axis of the
dimer. This movement is primarily based on changes in relative
orientation of the long helices (a14, a18 and a19) which join the
‘heads’ to the ‘tails’ (Figure 2D) [18]. Interestingly, in addition to
several positional changes in the a-helices and b-sheets forming the
CAP-like domains, perhaps the most significant difference between
S. pneumoniae and E. coli ParC structures is in the fold of the 100-
122 loop containing active-site Arg 117 and Tyr 118 residues
(Figure 2B and Figure 3A). In the ‘closed’ S. pneumoniae ParC
structure, the loop is positioned vertically and stands on the side of
the DNA-binding groove orienting the active-site tyrosine towards
the expected position of the DNA backbone and exposing the
active-site helices (a3 and a4) to the predicted protein-DNA
interface. By contrast, in the E. coli ParC, this loop forms two
additional turns one of which flips the active-site tyrosine upside-
down and moves it away from the dimer interface and surface of
the DNA-binding groove. In addition, the loop bends into the
DNA-binding groove and covers the active-site helices a3 and a4.
It seems possible that the open E. coli ParC structure corresponds
to the ‘DNA-free’ form of topoisomerase IV and that the evident
flexibility of the 100-122 loop is necessary to allow DNA binding
to the closed enzyme conformation.
S. pneumoniae ParC55 folds into a similar closed conformation to
that of E. coli GyrA (Figure 3B) However, interestingly, the DNA
binding site formed by the pneumococcal ParC55 dimer differs
markedly in its electrostatic charge distribution from both the E.
coli ParC and GyrA dimers (Figure 4). In particular, unlike E. coli
GyrA which has uniform positive charge within the DNA-binding
groove (except for the DNA scission active site and sides of the
neighboring ‘towers’), the DNA-binding groove of S. pneumoniae
ParC exhibits a pattern of alternating areas of positive and
negative charge (compare Figures 4A and 4C). These areas
correspond to the predicted positions of the backbone phosphates
and of the major/minor grooves of the bound DNA strand (see
below). To determine whether these distinctive charge distribu-
tions were retained across bacterial species, we modeled a number
of GyrA and ParC sequences on to the E. coli GyrA structure
(Figure S1). Modeling of S. pneumoniae ParC recapitulated the
experimental charge distribution seen in ParC55. S. pneumoniae
GyrA conformed almost exactly to the E. coli GyrA pattern. The
ParC and GyrA proteins of Staphylococcus aureus behaved like their
pneumococcal counterparts. There were also clear differences
between the cognate ParC and GyrA proteins of the Gram-
Figure 2. Structure of the ParC55 dimer and illustration of structurally related E. coli ParC and GyrA proteins. (A) Orthogonal views of the ParC55
biological dimer from S. pneumoniae. (B) Structure of the N-terminal region of E. coli ParC (18) (1ZVU) equivalent to ParC55 fragment. (C) Structure of
the N-terminal fragment (GyrA59) of E. coli GyrA [19] (1AB4). In (A), (B) and (C) the ‘towers’ and the CAP-like domains are shown in ice blue; the ‘tails’
along with adjacent helices a14, a18 and a19 are in ochre; the helix a4 in red; the helix a3 in cyan and the 100-122 loop in yellow. The active-site
tyrosines are shown in green. Residues Ser 79 and Asp 83 responsible for drug-resistance upon mutation are in purple. (D) Schematic conversion of
ParC55 from ‘closed’ (red) to ‘open’ (blue) conformation on the basis of the E. coli ParC structure. Panels were rendered using VMD [50] and Pov-Ray.
doi:10.1371/journal.pone.0000301.g002
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negative species Haemophilus influenzae and less so for Neisseria
gonorrhoeae. It is possible that charge distribution differences relate
to functional differences in DNA recognition and processing by the
two enzymes. Thus, E. coli GyrA uses its C-terminal domain to
bend DNA up to 180u presenting a T-segment in cis for passage
through the G-segment and thereby introducing negative super-
coils [24–28]. Unlike gyrase which has a 120–150-bp DNA
footprint [29–31], topo IV lacks negative supercoiling activity and
generally binds a short region of G-segment DNA (,30 bp) [32].
The C-terminal DNA binding domain of ParC is used to guide
intermolecular T segment translocation facilitating the decatena-
tion of linked DNA molecules [18,32]. It remains to be determined
whether differences in DNA substrate recognition and processing
by topo IV and gyrase are partially facilitated by differences in
charge distribution in the N-terminal DNA binding site of ParC/
GyrA.
Induced-fit model for sequence-specific DNA
binding and cleavage by ParC
In the ParC55 dimer, the catalytic Tyr 118 residues are 30 A˚ apart
and are not therefore optimally placed for attack of phosphodiester
bonds in the G-segment required for covalent ParC-DNA linkage
and DNA breakage. This situation also applies to the E. coli GyrA
dimer for which it was proposed that the G-segment is bound in
a distorted (perhaps single-stranded) form placing phosphodiester
bonds close enough for tyrosine attack [19]. Based on the ParC55
structure and the apparent conformational flexibility of the 100-
122 loop (Figure 3), we suggest a possible alternative to the
previously proposed DNA ‘‘bubble’’ mechanism [15]. In the new
model, the catalytic tyrosines are moved to attack DNA as
a natural consequence of G-segment recognition and binding by
the a3/a4 helices and by the 100-122 loop. Based on a knowledge
of the charge distribution for the DNA-binding groove of S.
pneumoniae ParC, differences in folding the 100-122 loop between S.
pneumoniae ParC and E. coli ParC and the known DNA sequence
preferences for S. pneumoniae ParC, we have modeled the protein-
DNA binding, DNA sequence recognition and cleavage process
using a 24-mer duplex corresponding to the strong E binding site
of topo IV [15] (Figure 5 and Movie S1). First, approximately two
turns of DNA helix are captured by the middle regions of the
protein heads positioning the phosphate backbone of the DNA
molecule against the positively charged grooves on the surface of
the CAP-like domains and neighboring towers, with the major
groove of the DNA against negatively charged middle regions of
the CAP-like domains. The two b-sheets with a joining loop
comprising amino acids Gly 166 to Pro 179 form a tight contact
with the major groove of the DNA (Figure 5A). In the next stage,
the helix a4 enters the minor groove of the DNA molecule
constituting the first step in DNA sequence recognition. The
possibility of the helix-turn-helix motif binding the minor groove
has previously been reported for human DNA repair protein O6-
alkylguanine-DNA alkyltransferase (AGT) [33]. Alternative bind-
ing of the helix a4 to either of the neighboring areas of the major
Figure 3. Structural comparison between active sites of topoisomerases
from gram-positive and gram-negative bacteria. (A) Stereo view of the
superposition of the active site of ParC from S. pneumoniae (red) and
ParC from E. coli (violet). (B) Stereo view of the superposition of the
active sites of ParC from S. pneumoniae (red) and GyrA from E. coli
(blue). The active-site tyrosines and arginines are represented in CPK
mode. Sites responsible for drug-resistance when mutated are
represented in Licorice mode. Panels were rendered using VMD [50]
and Pov-Ray.
doi:10.1371/journal.pone.0000301.g003
Figure 4. Electrostatic surface potential calculation. GRASP2 [51,52] electrostatic surface potentials within the DNA-binding grooves calculated for
equivalent N-terminal fragments of: (A) S. pneumoniae ParC (ParC55), (B) E. coli ParC, (C) E. coli GyrA. The E. coli ParC structure was manually brought
into the ‘closed’ conformation, but the experimentally determined fold of the active site was preserved. Negatively charged surfaces are in red and
positively charged surfaces are in blue.
doi:10.1371/journal.pone.0000301.g004
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groove of the DNA seems less attractive as it would require a strong
distortion of the active site which would physically push the active
site tyrosines away from the target backbone phosphates.
Driven by the process of the helix a4 binding to the minor
groove of the DNA, the helix a3 reorients itself moving into the
major groove of the DNA bringing the 100-122 loop closer to the
same groove. Then, the negatively charged 100-122 loop folds
onto and binds to the DNA major groove providing the second
step of DNA sequence recognition. As a direct consequence of
DNA recognition and binding by the 100-122 loop, the active site
tyrosine is moved close to the phosphate backbone of the DNA
allowing DNA cleavage to occur (Figure 5B). The process of
protein-DNA binding most likely involves slight opening of the
protein dimer interface (by approximately 9 A˚) and some bending
of the DNA molecule towards the active site of the protein (an
estimated radius of DNA curvature of about 70 A˚).
The model attractively accommodates key features of topo IV
action. First, unlike the proposal for DNA-binding to E. coli GyrA,
the model requires minimal distortion of protein and DNA
molecules [19]. Electrostatic potential calculated for the final stage
of the DNA binding process shows that the DNA backbone is
properly positioned against the positively charged regions of the
protein with the DNA major/minor grooves positioned against
the negatively charged regions of the DNA-binding groove along
the entire DNA molecule (Figure 5B). Second, it explains the
mechanism of selective DNA cleavage as arising from the DNA
sequence being ‘sampled’ both from the major groove (mainly by
the 100-122 loop and to some extent by the helix a3) and from the
Figure 5. DNA binding, recognition and cleavage by S. pneumoniae ParC. Initial (A) and final (B) stages of DNA binding and recognition are modeled
and shown as orthogonal stereo representations of the protein-DNA complex (top) together with the electrostatic surface potential of the DNA
binding groove (bottom). The ParC dimer is shown in cartoon mode; the helix a4 is in red, the helix a3 in cyan, the 100-122 loop in yellow and Gly 166
- Pro 179 domain in orange. The active-site tyrosines are shown in blue color using CPK mode and indicated by asterisks (magenta for unbound and
yellow for bound to the DNA states). The target 59-end phosphates of the DNA molecule are indicated by circles in magenta. The DNA molecule is
represented as a molecular surface model; the backbone is in pink, the cleavage points in purple, the base pairs involved in sequence specific
recognition in green and non-specific base pairs in silver. (C) Stereo view of the active site of the modelled protein-DNA complex of S. pneumoniae
ParC after cleavage and separation of the DNA fragments in cartoon (left) and surface (right) representation. Topo IV cleaves DNA with a 4-base
stagger and the active site tyrosines are covalently attached to the 59-ends of the DNA. Ser 79 and Asp 83 which upon mutation lead to quinolone
resistance in bacteria are shown in purple, the helix a4 is in cyan, the helix a3 in yellow, the 100-122 loop with active site tyrosine in red and Gly 166-
Pro 179 domain in orange. DNA molecule backbone is shown in yellow and side chains are in blue. The position of the covalent bond between the
active-site tyrosine and the target 59-end DNA backbone phosphate is indicated by a yellow asterisk in a magenta circle. Panels were rendered using
VMD [50], Pov-Ray and PyMOL [53].
doi:10.1371/journal.pone.0000301.g005
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minor groove (by the helix a4). Nucleotides+4, +6 and+8 (+1, 22
and 24 on the opposite strand) are placed close to the 100-122
loop and the helices a3/a4 (Figure 5C) consistent with the strong
DNA cleavage determinants observed at these positions for
pneumococcal topo IV [15]. Involvement of the 100-122 loop in
DNA sequence recognition may also help explain the divergence
of the DNA sequence preferences between ParC and GyrA from
different organisms despite very high conservation of the residues
within helices a3 and a4 which are involved in protein-DNA
contact formation (Figure S2).
Finally, the ParC55 structure and modeling of DNA recognition
are relevant to quinolone action. At the final stages of DNA bind-
ing and cleavage (Figure 5C), the quinolone resistance sites (Ser 79
and Asp 83, which are located within the helix a4 bound to the
minor groove of the DNA molecule) will be positioned next to the
39-end of the cleaved DNA strand with Ser 79 being closest to the
point of cleavage (Figure 5C). It is known that quinolones bind
strongly to topoisomerase-DNA complexes stabilizing the cleaved
form, but very weakly to the protein or duplex DNA alone [34,35].
Moreover, quinolones preferentially bind single-stranded DNA
[34]. These features indicate that the 39-end of the cleaved DNA
(-1 position) is a potential site for quinolone binding due to likely
distortion of the double-stranded DNA at the cleavage point, as
supported by clerocidin labeling experiments [36]. Sequence
homology (Figure 1C) and similarity in the disposition of muta-
tional hotspots in ParC and GyrA (Figure 3B) suggest that selective
quinolone targeting of ParC in S. pneumoniae and GyrA in E. coli
arises from structural conservation of high affinity drug binding
sites. The S. pneumoniae ParC55 structure presented here provides
a basis for approaching key aspects of DNA recognition and
quinolone action in gram-positive bacteria.
MATERIALS AND METHODS
Trypsin digestion of S. pneumoniae ParC and GyrA
ParC protein (10 mg) was incubated for 1 hour at 37uC with
bovine pancreatic trypsin (0.25 to 4 mg) in reaction buffer
containing 50 mM Tris-HCl, pH 7.5, 55 mM KCl, 2 mM MgCl2,
5 mM DTT and 10% glycerol (total volume of 20 ml). Reactions
were stopped by addition of SDS to a final concentration of 1%
followed by boiling for 5 minutes. Protein products were separated
in a NuPAGETM 4–12% Bis-Tris gradient gel run at 100 Volts for
2.5 hours and stained with Coomassie blue. Proteins were electro-
blotted onto polyvinylidene fluoride membrane and their N-
terminal sequences were determined using the Edman procedure
developed by Dr. Arthur Moir, University of Sheffield.
For tryptic digestion of S. pneumoniae GyrA protein, a time course
was performed. The reaction mixture contained 90 mg of GyrA
and 2.25 mg of trypsin in the same digestion buffer used for ParC
(total volume of 150 ml). At 0, 0.5, 1, 2, 5, 10 and 30 min, a 20 ml
aliquot was removed and the reaction was stopped. Proteins were
analysed by electrophoresis and sequenced as described for ParC.
Recombinant ParC, ParE, GyrA and GyrB were prepared as
described previously [8].
Expression of S. pneumoniae ParC55
A 1.4-kb fragment of the parC gene of S. pneumoniae strain 7785 was
amplified by PCR using forward primer N6894, 59-TGGGC-
TTTGTATCATATGTCTAAC (NdeI site overlapping the initi-
ation ATG codon is underlined) and reverse primer VPC4 (59-
TAGCTGTATCAATCTCGAGT-GCTTTCGCAG, parC nu-
cleotide position 1482 to 1452, engineered XhoI site underlined).
The NdeI-XhoI digested PCR product was ligated into pET29a,
yielding an expression plasmid that in E. coli inducibly expressed
the 55.5 kDa N-terminal ParC domain (ParC55). The protein
constitutes residues 1-490 of S. pneumoniae ParC bearing a C-
terminal hexahistidine tag and a single conserved amino acid
substitution (I489L) necessary for plasmid construction. Seleno-
methionine-substituted ParC55 was prepared by induction in E. coli
strain B834(DE3)pLysS (Novagen). To produce ParC55 Cys426,
the parC Arg426 codon of the expression plasmid was altered using
the Quikchange site-directed mutagenesis kit (Stratagene). Mutant
proteins were overexpressed in E. coli and purified by Ni2+-NTA
chromatography using the same conditions as for wild-type
ParC55.
Crystallization, data collection, structure solution
and refinement
The first crystallization of ParC55, the quinolone target from
gram-positive bacteria, and preliminary X-ray data analysis were
reported by our group (in Acta Cryst. (2005) A61, C176).
The purified ParC55 protein was dialyzed against 20 mM Tris-
HCl, pH 7.0, 200 mM NaCl, 10% glycerol, 1 mM b-mercap-
toethanol, 0.05% NaN3 then concentrated to 3-4 mg/ml using
PEG 35,000 at 4uC. ParC55 was crystallized by hanging drop
vapor diffusion in 24-well Limbro plates using 0.5 ml reservoir
volumes. Hanging drops were formed by mixing equal volumes of
protein and crystallization solutions. Crystals grew at ambient
temperature within 3 to 10 days and diffracted to 2.7 A˚. The best
diffracting wild-type ParC55 crystals were grown from 100 mM
Tris-HCl, pH 5.5, 200 mM NaCl, 1 mM b-mercaptoethanol,
0.05% NaN3 and 10% of 1:1 ethanol-isopropanol as precipitant.
Cys426 mutant was crystallized from 100 mM Tris-HCl, pH 6.5,
200 mM NaCl, 1 mM b-mercaptoethanol, 0.05% NaN3 using 4–
8% PEG 400 as a precipitant and 1 mM of hexamine cobalt
chloride as an additive.
The crystals were soaked for 3 to 5 seconds in cryoprotectant
solutions composed of either the crystallization solutions plus 25%
glycerol or 30% MPD, 150 mM NaCl, 0.05% NaN3, 20 mM
Tris-HCl, pH 7.0 and immediately frozen in a nitrogen cryo-
stream.
Data sets were collected at ESRF (Grenoble, France), SRS
(Daresbury Laboratory, UK) and at Rigaku Americas Corporation
(The Woodlands, Texas, USA), processed and integrated by
HKL2000 [37] (ParC Cys426) and XDS [38] (wild-type ParC55)
software. The cell dimensions for the best diffracting ParC crystal
were: a= 136.92 A˚, b= 137.85 A˚, c = 326.02 A˚, a= b= c= 90.0u.
Relatively high Rcryst (7–20% for different crystals) together with
high mosaicity (0.8u–1.4u) and peculiarities of the diffraction
patterns indicated that the crystal lattice was twinned. The space
group was established to be I222 with non-crystallographic sym-
metry operators mimicking the symmetry of the I4 space group. In
addition, most of the crystals were twinned with the twinning
operator (k,-h,l) equivalent to one of the symmetry operators
within I4. Data sets were tested for twinning using the UCLA
Merohedral Crystal Twinning Server [39] and CNS [40]. The
twinning fraction varied from 0.32 to 0.43 for different data sets.
The only data set which did not show signs of twinning was the
one collected on the Cys426 mutant using cobalt hexamine
chloride as an additive. The resolution of this data was 3.25 A˚ and
the model could not be refined to an R factor of lower than 30%,
which is probably due to an unaccounted contribution from
cobalt.
Several attempts to derive experimental ab initio phases from the
Se-Met and heavy atom derivatives of ParC were unsuccessful
most likely due to the high complexity of the problem, i.e. high
values of the twinning fraction and the twinning operator being
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close to the NCS operator. The structure was solved by Molecular
Replacement. The best two data sets in terms of resolution (wild-
type ParC55) and completeness (Cys426 mutant ParC55) were
used for the structure solution and refinement (Table 1).
The initial model was built using 3D-JIGSAW [41–43]. Due to
a higher sequence similarity, the GyrA from E. coli was picked
automatically as a prototype [19]. The rotational search per-
formed in CNS using the E. coli GyrA-based model gave the same
rotational solutions for different data sets and the results were
confirmed by AMoRe (CCP4) [44,45]. The initial translational
searches in I222 space group were not successful either in CNS or
in AMoRe. The data set collected on Cys426 mutant with
chromium wavelength (l= 2.29 A˚) was integrated in P1 space
group and used for a thorough translational search to overcome
this problem. The monomers were introduced into the trans-
lational search in P1 space group one-by-one in different orienta-
tions derived from the previous cross-rotational search and I222
space group symmetry operators. One sequential search solution
resulted in formation of a reasonable biological dimer and its
results were transferred back into the I222 space group giving
a half of the asymmetric unit content. The asymmetric unit was
completed in I222 space group using NCS-related dimer in-
troduced into the translational search. Finally, the asymmetric unit
was established to be composed of two biological dimers related to
each other by an approximately 90 degree rotation around the c
axis.
The structure was refined in CNS through several cycles of
simulated annealing/positional/B-factor refinement using strict
NCS operators in the initial cycles and restrained NCS operators
in the final ones. Manual backbone and side chain refitting were
performed using Coot [46]. The model was refined to R = 22.30%
(R-free = 27.55%) at 2.7 A˚ resolution using wild-type ParC55 data
(twinning fraction = 0.323).
The model was cross-checked using the anomalous data
collected on the chromium edge for the Cys426 mutant. An
anomalous difference Fourier map was generated in CCP4 [44]
Table 1. Summary of the crystallographic analysis
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Data set Wild type ParC55 ParC Cys426
Radiation source ESRF Grenoble, Beam Line BM 30A
Rigaku MicroMax-007HF generator fitted with
a chromium anode and a R-AXIS IV++detector
Wavelength (A˚) 0.91694 2.29090
Resolution (A˚) 2.67 3.25
Space group I222 I222
Cell dimensions
a, b, c (A˚) 136.92,137.85, 326.02 136.39, 137.64, 328.52
a, b, c (u) 90, 90, 90 90, 90, 90
Completeness (%) 97.2 96.0
Redundancy 5.4 8.2
Rsym(%)
* 9.3 (21.2) 7.3 (34.4)
No of sulfur sites (per monomer) 16 17
Resolution (A˚) 2.7 3.25
R/Rfree(%)
** 22.30/27.55 31.14/34.46
r.m.s. bond lengths (A˚) r.m.s. bond angles
0.013 1.72
*Rsym =SSj|,I.-Ij|/S,I..
**R/Rfree =S||Fobs|-|Fcalc||/|Fobs|, where the working and free R-factors are calculated using the working and free reflection sets, respectively. The free reflections were held
aside throughout refinement.
doi:10.1371/journal.pone.0000301.t001
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Figure 6. Electron density maps confirming the molecular replacement
solution. (A) Superposition of the anomalous difference Fourier map
calculated using Cys426 data collected on the chromium edge
contoured at 3.5s with the final refined model of ParC55. Panels were
rendered using Coot [46]. (B) Stereo view of a region of the 2Fobs-Fcalc
electron density map from wild-type ParC55 data contoured at 1.5s
with the final refined model superimposed.
doi:10.1371/journal.pone.0000301.g006
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using the ParC Cys426 data set collected at the chromium
wavelength and phases from the refined wild-type ParC55 model.
The map showed clear anomalous peaks around sulfur atoms of
corresponding methionines as well as cysteine 426, confirming the
molecular replacement solution (Figure 6A).
Close inspection of the 2Fobs-Fcalc electron density maps built
using both wild-type ParC55 and Cys426 mutant data sets have
shown a very good coverage for most of the backbone and side-
chains (ure 6B). The overall B-factors of the structure are relatively
high with the average value of 67.42 A˚2 and are similar to those
shown for GyrA from E. coli, which indicates a high level of
flexibility of the molecules [19]. The terminal residues (1 to 27 and
483 to 496) as well as the residues in flexible regions:
Chain A: 172, 283–285, 291–295, 301–304, 408;
Chain B: 172, 299, 408;
Chain C: 306, 408–409;
Chain D: 110, 171–174, 253, 282–284, 316–318, 408–409
were omitted from the final structure because no convincing
electron density was observed for them.
The final Ramachandran plot indicated that most of the
residues are in the favored regions: 83.2% most favored, 13.8%
allowed, 2.3% generously allowed, 0.7% disallowed according to
PROCHECK [47,48].
Data deposition: The atomic coordinates and structure factors
have been deposited with the Protein Data Bank, www.rcsb.org
(PDB ID code 2NOV).
SUPPORTING INFORMATION
Figure S1 Electrostatic surface potential modeling. GRASP2
[51,52] electrostatic surface potentials within the DNA-binding
grooves calculated for DNA-binding domains of topoisomerases
IIA from different organisms using models generated by 3D-
JIGSAW [41–43] on the base of the known structure of E. coli
GyrA (1AB4).
Found at: doi:10.1371/journal.pone.0000301.s001 (3.64 MB
PDF)
Figure S2 Modeling of the DNA sequence recognition by
topoisomerase IV. (A) Amino acid sequence alignment for the
regions of GyrA and ParC from E. coli and S. pneumoniae com-
prising helices a3 and a4 and the 100-122 loop. The residues
within the a-helices which are likely to interact directly with the
incoming DNA helix are indicated by color (red for a3 and blue
for a4) and asterisks. Active site tyrosines and arginines are in
green. (B) Model of the bound state for the protein-DNA complex
between S. pneumoniae ParC and the DNA E site [15]. The DNA is
in Licorice mode and the protein is in cartoon mode. The
positions on the DNA helix are given by numbers in yellow circles.
The nucleotides are indicated by square boxes. Amino acids of the
100-122 loop are indicated by ovals with corresponding names.
Helix a4 is in cyan and helix a3 is in yellow. Active site tyrosine
and arginine are in CPK mode and the point of the DNA cleavage
is indicated by yellow asterisk in red circle. Ser 79 and Asp 83 are
shown using VDW representation and are in yellow and red
respectively. The panel was generated using VMD [50] and Pov-
Ray.
Found at: doi:10.1371/journal.pone.0000301.s002 (3.14 MB
PDF)
Movie S1 A schematic process of DNA binding and recognition
by S. pneumoniae ParC. The process is shown both in cartoon and
electrostatic potential surface modes. The positions of the active-
site tyrosines are indicated by arrows when the tyrosines approach
the target DNA backbone phosphates. The DNA backbone is in
rose, the base pairs involved in sequence specific DNA recognition
are in green, the nucleotides adjacent to the cleavage points are in
purple in Licorice mode and the non-specific base pairs are in
silver. The active-site tyrosines of the ParC dimer are represented
in CPK mode in blue. The helix a3 is in cyan, the helix a4 is in
red, the 100-122 loop is in yellow and the Gly 166-Pro 179 region
is in orange. The movie was generated using VMD [50], Pov-Ray
and PyMOL [53].
Found at: doi:10.1371/journal.pone.0000301.s003 (4.77 MB
MPG)
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